fluoxetine has been researched along with Delirium in 13 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Delirium: A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This man's delirium is consistent with fluoxetine intoxication, which appears to have resulted from inhibition of hepatic cytochrome P450 metabolism by clarithromycin." | 7.69 | Delirium probably induced by clarithromycin in a patient receiving fluoxetine. ( Hewlett, TJ; MacKenzie, SL; Pollak, PT; Sketris, IS, 1995) |
| "Recent studies have shown that withdrawal symptoms are common with paroxetine, venlafaxine and fluvoxamine, but relatively rare and mild with fluoxetine cessation, likely as a result of its longer half-life." | 5.35 | Delirium following abrupt discontinuation of fluoxetine. ( Blum, D; Lansberg, M; Maldonado, J; Meyer, E, 2008) |
| "This man's delirium is consistent with fluoxetine intoxication, which appears to have resulted from inhibition of hepatic cytochrome P450 metabolism by clarithromycin." | 3.69 | Delirium probably induced by clarithromycin in a patient receiving fluoxetine. ( Hewlett, TJ; MacKenzie, SL; Pollak, PT; Sketris, IS, 1995) |
| "Recent studies have shown that withdrawal symptoms are common with paroxetine, venlafaxine and fluvoxamine, but relatively rare and mild with fluoxetine cessation, likely as a result of its longer half-life." | 1.35 | Delirium following abrupt discontinuation of fluoxetine. ( Blum, D; Lansberg, M; Maldonado, J; Meyer, E, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 9 (69.23) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chistyakova, Y | 1 |
| Amos, J | 1 |
| Chan, CH | 1 |
| Liu, HC | 1 |
| Huang, MC | 1 |
| Blum, D | 1 |
| Maldonado, J | 1 |
| Meyer, E | 1 |
| Lansberg, M | 1 |
| Rothschild, AJ | 1 |
| Kasantikul, D | 1 |
| Pollak, PT | 1 |
| Sketris, IS | 1 |
| MacKenzie, SL | 1 |
| Hewlett, TJ | 1 |
| Singh, RK | 1 |
| Gupta, AK | 1 |
| Singh, B | 1 |
| Leinonen, E | 1 |
| Koponen, H | 1 |
| Lepola, U | 1 |
| Tracy, TS | 1 |
| Johns, M | 1 |
| Paul, KL | 1 |
| Bhatara, VS | 1 |
| Preskorn, SH | 1 |
| Beber, JH | 1 |
| Faul, JC | 1 |
| Hirschfeld, RM | 1 |
| Skowron, DM | 1 |
| Gutierrez, MA | 1 |
| Epstein, S | 1 |
| Figiel, GS | 1 |
| Krishnan, KR | 1 |
| Breitner, JC | 1 |
| Nemeroff, CB | 1 |
13 other studies available for fluoxetine and Delirium
| Article | Year |
|---|---|
Delirium associated with lamotrigine and fluoxetine treatment.
Topics: Adult; Antipsychotic Agents; Delirium; Female; Fluoxetine; Humans; Lamotrigine; Selective Serotonin | 2008 |
Delirium associated with concomitant use of low-dose bupropion sustained release and fluoxetine.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; Delirium; Depressi | 2006 |
Delirium following abrupt discontinuation of fluoxetine.
Topics: Delirium; Female; Fluoxetine; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Substanc | 2008 |
Delirium: an SSRI-benztropine adverse effect?
Topics: Adult; Age Factors; Aged; Benztropine; Delirium; Drug Interactions; Fluoxetine; Humans; Middle Aged; | 1995 |
Reversible delirium after discontinuation of fluoxetine.
Topics: Aged; Delirium; Depressive Disorder; Female; Fluoxetine; Humans | 1995 |
Delirium probably induced by clarithromycin in a patient receiving fluoxetine.
Topics: Clarithromycin; Delirium; Drug Interactions; Fluoxetine; Humans; Male; Middle Aged | 1995 |
Acute organic brain syndrome after fluoxetine treatment.
Topics: Aged; Basal Ganglia Diseases; Delirium; Depressive Disorder; Dose-Response Relationship, Drug; Drug | 1995 |
Delirium during fluoxetine treatment. A case report.
Topics: Aged; Delirium; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Female; Fl | 1993 |
Comment: delirium probably induced by clarithromycin in a patient receiving fluoxetine.
Topics: Clarithromycin; Delirium; Drug Therapy, Combination; Fluoxetine; Humans; Male | 1996 |
Anticholinergic delirium possibly associated with protriptyline and fluoxetine.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cholinergic Antagonists; | 1997 |
Serious adverse effects of combining fluoxetine and tricyclic antidepressants.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Delirium; Drug Interactions; Drug Therapy, Combinatio | 1990 |
Precaution with titrating nortriptyline after the use of fluoxetine.
Topics: Delirium; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Psychoses, Substance-Induced | 1990 |
Radiologic correlates of antidepressant-induced delirium: the possible significance of basal-ganglia lesions.
Topics: Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents; Basal Ganglia; Basal Ganglia Diseases | 1989 |